Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China
Professor Yi-Long Wu is a vice-president of the Guangdong General Hospital& Guangdong Academy of Medical Sciences and a director of Guangdong Lung Cancer Institute. He is the president of Chinese Society of Clinical Oncology (CSCO), the former director of Chinese Society of Lung Cancer (CSLC), the President of the Chinese Thoracic Oncology Group(C-TONG), the President of the Fifth International Chinese Society of Thoracic Surgery (ICSTS), a Fellow of the American College of Surgeons, a Member of staging committee and Board of Directors of the International Association Study of Lung Cancer (IASLC) and a Member of the International Affairs Committee of ASCO.
He graduated from Sun Yat-sen University of Medical Sciences in 1982, and completed his thoracic surgery training in Germany in 1989. His main research interests are the multidisciplinary synthetic therapy on lung cancer from basic science to bedside and evidence-based medicine in oncology. He is leading the Chinese lung cancer field and has been a Principle Investigator or Co-PI in more than 90 multi-center clinical trials. He has contributed 20 books on cancer and has published more than 300 articles in peer-reviewed journals including J Clin Oncol, Lancet Oncol, New Engl J Med, Cancel Cell and J Thorac Oncol. He also serves on the editorial boards of Cancer Letters, Annals of Surgical Oncology, Lung Cancer Management, International Journal of Biological Marker and General Thoracic and Cardiovascular Surgery. He is editor-in-chief of Journal of Evidence-based Medicine, Journal of Thoracic Oncology (Chinese Edition), and Oncologist (Chinese Edition) etc.